NLR对局晚期口腔鳞状细胞癌患者术前尼妥珠单抗联合新辅助化疗疗效预测价值研究
The value of NLR in predicting the efficacy of preoperative nimotuzumab combined with neoadjuvant chemotherapy for local advanced oral squamous cell carcinoma
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |